Vault-13

Eversept Partners, LP

NEW YORK, NY · CIK 1697013 · 13F filing filed 2023-11-08

SEC-registered investment adviser since 2017 · limited partnership

As an employer

Where they work

people there (dot area)number not reportedmain officeHover or tap a dot. Australian and UK companies are placed at their business or registered address, with their staff across the whole country.

Offices

From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.

CityCountryPeople
New York, NY (main office)United States United Statesabout 4
San Francisco, CAUnited States United States1

Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.

$1.1bn reported value -11.5% vs Q1 2021
69positions
53.1%in top 10
19 new 15 added 30 reduced 24 sold out vs Q1 2021

Options: 11 call positions ($199.4m notional), 7 put positions ($221.1m notional) – listed below, not included above.

Holdings, Q2 2021

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 UNITED THERAPEUTICS CORP DEL COM UTHR UTHR 442,945 $79.5m7.36% 7.36% ReducedShares held: Q3 2020 240.9k, Q4 2020 458.6k, Q1 2021 486.5k, Q2 2021 442.9k -43.6k -43,584 -9.0%
2 AMARIN CORP PLC SPONS ADR NEW SPONS ADR NEW 16,669,471 $73.0m6.76% 6.76% ReducedShares held: Q3 2020 10.7m, Q4 2020 15.9m, Q1 2021 16.9m, Q2 2021 16.7m -227.3k -227,325 -1.4%
3 ARK ETF TR GENOMIC REV ETF ARKG ARKG 773,480 $71.5m6.63% 6.63% ReducedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 806.9k, Q2 2021 773.5k -33.5k -33,452 -4.2%
4 HORIZON THERAPEUTICS PUB L SHS HZNP HZNP 666,738 $62.4m5.78% 5.78% ReducedShares held: Q3 2020 607.8k, Q4 2020 531.0k, Q1 2021 695.5k, Q2 2021 666.7k -28.7k -28,721 -4.1%
5 ASTRAZENECA PLC SPONSORED ADR SPONSORED ADR 985,722 $59.0m5.47% 5.47% ReducedShares held: Q3 2020 60.9k, Q4 2020 852.4k, Q1 2021 992.3k, Q2 2021 985.7k -6.6k -6,593 -0.7%
6 COMMUNITY HEALTH SYS INC NEW COM CYH CYH 3,821,729 $59.0m5.46% 5.46% AddedShares held: Q3 2020 0, Q4 2020 12.8k, Q1 2021 2.4m, Q2 2021 3.8m +1.4m +1,415,895 58.9%
7 DANAHER CORPORATION COM DHR DHR 204,705 $55.0m5.09% 5.09% AddedShares held: Q3 2020 31.4k, Q4 2020 126.3k, Q1 2021 177.5k, Q2 2021 204.7k +27.2k +27,171 15.3%
8 ACCELERON PHARMA INC COM XLRN XLRN 335,045 $42.0m3.89% 3.89% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 242.0k, Q2 2021 335.0k +93.1k +93,064 38.5%
9 TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS SPONSORED ADS 3,804,405 $37.7m3.49% 3.49% ReducedShares held: Q3 2020 2.4m, Q4 2020 2.7m, Q1 2021 4.4m, Q2 2021 3.8m -550.4k -550,351 -12.6%
10 AVANTOR INC COM AVTR AVTR 974,637 $34.6m3.21% 3.21% AddedShares held: Q3 2020 0, Q4 2020 920.6k, Q1 2021 959.0k, Q2 2021 974.6k +15.7k +15,650 1.6%
11 BRISTOL-MYERS SQUIBB CO COM BMY BMY 478,328 $32.0m2.96% 2.96% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 478.3k
12 ASCENDIS PHARMA A/S SPONSORED ADR SPONSORED ADR 241,774 $31.8m2.95% 2.95% ReducedShares held: Q3 2020 161.0k, Q4 2020 187.0k, Q1 2021 311.9k, Q2 2021 241.8k -70.1k -70,093 -22.5%
13 QIAGEN NV SHS NEW SHS NEW 651,035 $31.5m2.92% 2.92% AddedShares held: Q3 2020 167.5k, Q4 2020 336.9k, Q1 2021 454.7k, Q2 2021 651.0k +196.3k +196,314 43.2%
14 FATE THERAPEUTICS INC COM FATE FATE 346,347 $30.1m2.78% 2.78% AddedShares held: Q3 2020 535.0k, Q4 2020 399.5k, Q1 2021 321.8k, Q2 2021 346.3k +24.6k +24,587 7.6%
15 ORTHO CLINICAL DIAGNOSTICS H ORD SHS OCDX OCDX 1,394,284 $29.9m2.76% 2.76% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 1.4m, Q2 2021 1.4m +19.1k +19,056 1.4%
16 AMNEAL PHARMACEUTICALS INC COM STK CL A AMRX AMRX 5,624,725 $28.8m2.67% 2.67% AddedShares held: Q3 2020 2.7m, Q4 2020 1.2m, Q1 2021 4.8m, Q2 2021 5.6m +869.2k +869,245 18.3%
17 ENVISTA HOLDINGS CORPORATION COM NVST NVST 656,098 $28.3m2.63% 2.63% ReducedShares held: Q3 2020 0, Q4 2020 861.4k, Q1 2021 732.7k, Q2 2021 656.1k -76.6k -76,586 -10.4%
18 ORGANON & CO COMMON STOCK OGN OGN 699,696 $21.2m1.96% 1.96% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 699.7k
19 IONIS PHARMACEUTICALS INC COM IONS IONS 442,000 $17.6m1.63% 1.63% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 442.0k
20 R1 RCM INC COM RCM RCM 770,000 $17.1m1.59% 1.59% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 770.0k
21 HEALTHEQUITY INC COM HQY HQY 197,500 $15.9m1.47% 1.47% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 197.5k
22 AMN HEALTHCARE SVCS INC COM AMN AMN 159,101 $15.4m1.43% 1.43% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 159.1k
23 OMNICELL COM COM OMCL OMCL 98,366 $14.9m1.38% 1.38% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 98.4k
24 MCKESSON CORP COM MCK MCK 75,000 $14.4m1.33% 1.33% ReducedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 123.0k, Q2 2021 75.0k -48.0k -47,983 -39.0%
25 TARO PHARMACEUTICAL INDS LTD SHS TARO TARO 174,249 $12.5m1.16% 1.16% AddedShares held: Q3 2020 141.9k, Q4 2020 152.3k, Q1 2021 164.4k, Q2 2021 174.2k +9.9k +9,871 6.0%
26 ARK ETF TR INNOVATION ETF ARKK ARKK 85,000 $11.1m1.03% 1.03% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 82.0k, Q2 2021 85.0k +3.0k +3,000 3.7%
27 VERTEX PHARMACEUTICALS INC COM VRTX VRTX 54,500 $11.0m1.02% 1.02% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 54.5k
28 THE CIGNA GROUP COM CI CI 41,745 $9.9m0.92% 0.92% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 40.0k, Q2 2021 41.7k +1.7k +1,745 4.4%
29 MAGELLAN HEALTH INC COM NEW MGLN MGLN 104,700 $9.9m0.91% 0.91% UnchangedShares held: Q3 2020 0, Q4 2020 104.7k, Q1 2021 104.7k, Q2 2021 104.7k
30 ALNYLAM PHARMACEUTICALS INC COM ALNY ALNY 51,136 $8.7m0.80% 0.80% ReducedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 80.9k, Q2 2021 51.1k -29.8k -29,801 -36.8%
31 ZOGENIX INC COM NEW ZGNX ZGNX 495,860 $8.6m0.79% 0.79% ReducedShares held: Q3 2020 865.2k, Q4 2020 909.7k, Q1 2021 823.2k, Q2 2021 495.9k -327.4k -327,369 -39.8%
32 HUMANA INC COM HUM HUM 18,656 $8.3m0.77% 0.77% ReducedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 24.8k, Q2 2021 18.7k -6.2k -6,183 -24.9%
33 OPTION CARE HEALTH INC COM NEW OPCH OPCH 289,297 $6.3m0.59% 0.59% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 289.3k
34 OUTSET MED INC COM OM OM 107,300 $5.4m0.50% 0.50% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 107.3k
35 CENTENE CORP DEL COM CNC CNC 68,000 $5.0m0.46% 0.46% ReducedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 91.1k, Q2 2021 68.0k -23.1k -23,120 -25.4%
36 SURGALIGN HOLDINGS INC COM RTIX RTIX 3,882,096 $4.9m0.45% 0.45% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 2.6m, Q2 2021 3.9m +1.2m +1,242,312 47.1%
37 AFFIMED N V COM COM 566,942 $4.8m0.45% 0.45% ReducedShares held: Q3 2020 1.2m, Q4 2020 964.7k, Q1 2021 1.0m, Q2 2021 566.9k -479.2k -479,187 -45.8%
38 INTRA-CELLULAR THERAPIES INC COM ITCI ITCI 117,462 $4.8m0.44% 0.44% ReducedShares held: Q3 2020 176.8k, Q4 2020 356.2k, Q1 2021 300.6k, Q2 2021 117.5k -183.1k -183,125 -60.9%
39 GLAXOSMITHKLINE PLC SPONSORED ADR SPONSORED ADR 112,679 $4.6m0.43% 0.43% ReducedShares held: Q3 2020 64.4k, Q4 2020 946.6k, Q1 2021 852.2k, Q2 2021 112.7k -739.5k -739,527 -86.8%
40 CULLINAN THERAPEUTICS INC COM CGEM CGEM 163,880 $4.2m0.39% 0.39% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 163.9k
41 DEXCOM INC COM DXCM DXCM 9,525 $4.1m0.38% 0.38% ReducedShares held: Q3 2020 0, Q4 2020 2.5k, Q1 2021 18.7k, Q2 2021 9.5k -9.2k -9,216 -49.2%
42 ELEVANCE HEALTH INC COM ELV ELV 10,132 $3.9m0.36% 0.36% ReducedShares held: Q3 2020 0, Q4 2020 65.8k, Q1 2021 63.9k, Q2 2021 10.1k -53.8k -53,760 -84.1%
43 KADMON HLDGS INC COM KDMN KDMN 894,995 $3.5m0.32% 0.32% ReducedShares held: Q3 2020 0, Q4 2020 2.4m, Q1 2021 1.4m, Q2 2021 895.0k -478.1k -478,124 -34.8%
44 EXELIXIS INC COM EXEL EXEL 180,000 $3.3m0.30% 0.30% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 180.0k
45 AUTOLUS THERAPEUTICS PLC SPON ADS AUTL AUTL 473,074 $3.1m0.29% 0.29% NewShares held: Q3 2020 0, Q4 2020 155.0k, Q1 2021 0, Q2 2021 473.1k
46 MARAVAI LIFESCIENCES HLDGS I COM CL A MRVI MRVI 75,000 $3.1m0.29% 0.29% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 75.0k
47 INTERSECT ENT INC COM XENT XENT 175,389 $3.0m0.28% 0.28% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 75.4k, Q2 2021 175.4k +100.0k +100,000 132.7%
48 CENTURY THERAPEUTICS INC COM IPSC IPSC 100,901 $3.0m0.27% 0.27% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 100.9k
49 LIQUIDIA CORPORATION COM NEW LQDA LQDA 979,049 $2.8m0.26% 0.26% AddedShares held: Q3 2020 182.8k, Q4 2020 0, Q1 2021 500.0k, Q2 2021 979.0k +479.0k +479,039 95.8%
50 TG THERAPEUTICS INC COM TGTX TGTX 69,760 $2.7m0.25% 0.25% ReducedShares held: Q3 2020 1.0m, Q4 2020 863.9k, Q1 2021 762.6k, Q2 2021 69.8k -692.8k -692,829 -90.8%
51 INTUITIVE SURGICAL INC COM NEW ISRG ISRG 2,583 $2.4m0.22% 0.22% UnchangedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 2.6k, Q2 2021 2.6k
52 AGILENT TECHNOLOGIES INC COM A A 15,261 $2.3m0.21% 0.21% UnchangedShares held: Q3 2020 0, Q4 2020 5.0k, Q1 2021 15.3k, Q2 2021 15.3k
53 HEALTHSTREAM INC COM HSTM HSTM 77,812 $2.2m0.20% 0.20% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 77.8k
54 OCULAR THERAPEUTIX INC COM OCUL OCUL 150,000 $2.1m0.20% 0.20% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 150.0k
55 ALPHA HEALTHCARE ACQUISTN CO CL A CL A 205,026 $2.1m0.19% 0.19% ReducedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 239.0k, Q2 2021 205.0k -34.0k -34,000 -14.2%
56 HCA HEALTHCARE INC COM HCA HCA 8,314 $1.7m0.16% 0.16% ReducedShares held: Q3 2020 52.4k, Q4 2020 16.8k, Q1 2021 85.4k, Q2 2021 8.3k -77.1k -77,095 -90.3%
57 SERES THERAPEUTICS INC COM COM 59,560 $1.4m0.13% 0.13% ReducedShares held: Q3 2020 0, Q4 2020 334.0k, Q1 2021 215.3k, Q2 2021 59.6k -155.7k -155,716 -72.3%
58 IQVIA HLDGS INC COM IQV IQV 5,712 $1.4m0.13% 0.13% ReducedShares held: Q3 2020 0, Q4 2020 4.1k, Q1 2021 5.9k, Q2 2021 5.7k -209 -209 -3.5%
59 TELIGENT INC NEW COM NEW COM NEW 2,500,260 $1.3m0.12% 0.12% UnchangedShares held: Q3 2020 305.4k, Q4 2020 0, Q1 2021 2.5m, Q2 2021 2.5m
60 IMMUNOVANT INC COM IMVT IMVT 110,183 $1.2m0.11% 0.11% ReducedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 230.2k, Q2 2021 110.2k -120.0k -120,000 -52.1%
61 NATERA INC COM NTRA NTRA 9,314 $1.1m0.10% 0.10% ReducedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 57.7k, Q2 2021 9.3k -48.4k -48,386 -83.9%
62 LEXICON PHARMACEUTICALS INC COM NEW LXRX LXRX 229,289 $1.1m0.10% 0.10% ReducedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 410.6k, Q2 2021 229.3k -181.3k -181,304 -44.2%
63 F-STAR THERAPEUTICS INC COM COM 100,000 $859.0k0.08% 0.08% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 100.0k
64 HESKA CORP COM RESTRC NEW HSKA HSKA 3,412 $783.8k0.07% 0.07% ReducedShares held: Q3 2020 158.8k, Q4 2020 76.2k, Q1 2021 11.0k, Q2 2021 3.4k -7.6k -7,628 -69.1%
65 ENSIGN GROUP INC COM ENSG ENSG 8,973 $778.2k0.07% 0.07% ReducedShares held: Q3 2020 318.9k, Q4 2020 208.5k, Q1 2021 28.9k, Q2 2021 9.0k -19.9k -19,910 -68.9%
66 GOHEALTH INC COM CL A COM CL A 68,899 $772.4k0.07% 0.07% UnchangedShares held: Q3 2020 13.1k, Q4 2020 29.7k, Q1 2021 68.9k, Q2 2021 68.9k
67 REPLIGEN CORP COM RGEN RGEN 3,692 $737.0k0.07% 0.07% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 1.4k, Q2 2021 3.7k +2.3k +2,264 158.5%
68 CROSS CTRY HEALTHCARE INC COM CCRN CCRN 30,810 $508.7k0.05% 0.05% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 30.8k
69 GUARDANT HEALTH INC COM GH GH 1,809 $224.7k0.02% 0.02% ReducedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 40.2k, Q2 2021 1.8k -38.4k -38,438 -95.5%

Sold out since Q1 2021

SecurityTickerShares held beforeValue then
ALEXION PHARMACEUTICALS INC ALXN ALXN 465,983 $71.3m466.0k shares
CATALENT INC CTLT CTLT 163,114 $17.2m163.1k shares
BECTON DICKINSON & CO BDX BDX 68,383 $16.6m68.4k shares
BIOHAVEN PHARMACTL HLDG CO L BHVN BHVN 242,172 $16.6m242.2k shares
DECIPHERA PHARMACEUTICALS IN DCPH DCPH 345,717 $15.5m345.7k shares
ACADIA PHARMACEUTICALS INC ACAD ACAD 420,000 $10.8m420.0k shares
ARGENX SE ARGX ARGX 35,886 $9.9m35.9k shares
MANNKIND CORP MNKD MNKD 2,165,383 $8.5m2.2m shares
NOVAVAX INC NVAX NVAX 33,473 $6.1m33.5k shares
LUMINEX CORP DEL 135,471 $4.3m135.5k shares
FIVE PRIME THERAPEUTICS INC FPRX FPRX 93,280 $3.5m93.3k shares
SURMODICS INC SRDX SRDX 47,906 $2.7m47.9k shares
EXAGEN INC XGN XGN 104,437 $1.8m104.4k shares
PROTHENA CORP PLC PRTA PRTA 68,575 $1.7m68.6k shares
KEROS THERAPEUTICS INC KROS KROS 27,631 $1.7m27.6k shares
CONFORMIS INC CFMS CFMS 1,541,978 $1.5m1.5m shares
CHEWY INC CHWY CHWY 13,100 $1.1m13.1k shares
RITE AID CORP RAD RAD 54,025 $1.1m54.0k shares
INFLARX NV IFRX IFRX 268,634 $1.0m268.6k shares
CABALETTA BIO INC CABA CABA 76,849 $853.0k76.8k shares
IMMUTEP LTD 249,895 $767.2k249.9k shares
APELLIS PHARMACEUTICALS INC APLS APLS 12,900 $553.5k12.9k shares
QUIDEL CORP QDEL QDEL 4,132 $528.6k4.1k shares
APTOSE BIOSCIENCES INC 80,000 $478.0k80.0k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
SPDR S&P 500 ETF TR SPY · Put SPYPut 250,000 $107.0m250.0k shares Added
INVESCO QQQ TR QQQ · Put QQQPut 250,000 $88.6m250.0k shares New
GLAXOSMITHKLINE PLC Call Call 1,403,700 $55.9m1.4m shares Added
BIOGEN INC BIIB · Call BIIBCall 115,600 $40.0m115.6k shares New
VERTEX PHARMACEUTICALS INC VRTX · Call VRTXCall 173,300 $34.9m173.3k shares Added
SPDR SER TR XBI · Call XBICall 200,000 $27.1m200.0k shares New
ARK ETF TR ARKG · Call ARKGCall 199,000 $18.4m199.0k shares New
SPDR SER TR XBI · Put XBIPut 100,000 $13.5m100.0k shares New
ISHARES TR TIP · Put TIPPut 70,000 $9.0m70.0k shares New
TELADOC HEALTH INC TDOC · Call TDOCCall 40,000 $6.7m40.0k shares New
HORIZON THERAPEUTICS PUB L HZNP · Call HZNPCall 70,000 $6.6m70.0k shares New
MERCK & CO INC MRK · Call MRKCall 48,700 $3.8m48.7k shares New
NOVAVAX INC NVAX · Call NVAXCall 10,000 $2.1m10.0k shares Unchanged
ACADIA PHARMACEUTICALS INC ACAD · Call ACADCall 84,600 $2.1m84.6k shares Added
TEVA PHARMACEUTICAL INDS LTD Call Call 192,900 $1.9m192.9k shares New
GLOBAL BLOOD THERAPEUTICS IN GBT · Put GBTPut 40,000 $1.4m40.0k shares New
FREQUENCY THERAPEUTICS INC Put Put 92,500 $921.3k92.5k shares Reduced
BIOGEN INC BIIB · Put BIIBPut 2,000 $692.5k2.0k shares New

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
COMMUNITY HEALTH SYS INC NEW CYH · 13G · filed 2026-02-17 CYH 5.7%≈ $26.5m +1.3 pts 13G 2026-02-17